Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 210,258,564 papers from all fields of science
Search
Sign In
Create Free Account
GALNT14 gene
Known as:
UDP-N-ACETYL-ALPHA-D-GALACTOSAMINE:POLYPEPTIDE N-ACETYLGALACTOSAMINYLTRANSFERASE 14
, polypeptide N-acetylgalactosaminyltransferase 14
, polypeptide GalNAc transferase 14
Expand
National Institutes of Health
Create Alert
Alert
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
Review
2020
Review
2020
GALNT14: An Emerging Marker Capable of Predicting Therapeutic Outcomes in Multiple Cancers
Wey-Ran Lin
,
C. Yeh
International Journal of Molecular Sciences
2020
Corpus ID: 211522345
Members of the polypeptide N-acetylgalactosaminyltransferase (GALNT) family function as the initiating enzymes that catalyze…
Expand
Highly Cited
2016
Highly Cited
2016
GALNT14 promotes lung-specific breast cancer metastasis by modulating self-renewal and interaction with the lung microenvironment
K. Song
,
M. Park
,
Tulip Nandu
,
Shrikanth S. Gadad
,
Sang-Cheol Kim
,
Mi-Young Kim
Nature Communications
2016
Corpus ID: 16341353
Some polypeptide N-acetyl-galactosaminyltransferases (GALNTs) are associated with cancer, but their function in organ-specific…
Expand
2016
2016
MiR-125a regulates ovarian cancer proliferation and invasion by repressing GALNT14 expression.
Juan Yang
,
Gui-yuan Li
,
Keqiang Zhang
Biomedicine & pharmacotherapy = Biomedecine…
2016
Corpus ID: 3897219
2016
2016
GALNT14 genotype effectively predicts the therapeutic response in unresectable hepatocellular carcinoma treated with transcatheter arterial chemoembolization.
Kung-Hao Liang
,
Chih-Lang Lin
,
+9 authors
C. Yeh
Pharmacogenomics (London)
2016
Corpus ID: 35470782
AIM Transcatheter arterial chemoembolization is currently the standard treatment in hepatocellular carcinoma patients with…
Expand
Highly Cited
2015
Highly Cited
2015
GALNT14 mediates tumor invasion and migration in breast cancer cell MCF‐7
Tian Huan-na
,
Zuo Tao
,
+11 authors
Wu Chen
Molecular Carcinogenesis
2015
Corpus ID: 27862501
Aberrant glycosylation is a hallmark of most human cancers and affects many cellular properties, including cell proliferation…
Expand
2015
2015
Identification of GALNT14 as a novel neuroblastoma predisposition gene
Marilena De Mariano
,
Roberta Gallesio
,
+7 authors
L. Longo
OncoTarget
2015
Corpus ID: 11124414
Although several genes have been associated to neuroblastoma (NB) predisposition and aggressiveness, further genes are likely…
Expand
2014
2014
GALNT14 genotype, α-fetoprotein and therapeutic side effects predict post-chemotherapy survival in patients with advanced hepatocellular carcinoma.
Wey-Ran Lin
,
Chao-Wei Hsu
,
+4 authors
C. Yeh
Molecular and clinical oncology
2014
Corpus ID: 45227932
In addition to targeted agents, chemotherapy is currently considered to be a treatment option for patients with advanced…
Expand
2013
2013
The mucin-type glycosylating enzyme polypeptide N-acetylgalactosaminyltransferase 14 promotes the migration of ovarian cancer by modifying mucin 13.
Ranran Wang
,
Chao Yu
,
Dezhang Zhao
,
Mingjun Wu
,
Zhu Yang
Oncology Report
2013
Corpus ID: 16016816
A high expression of O-glycosylated proteins is one of the prominent characteristics of ovarian carcinoma cells associated with…
Expand
2011
2011
GALNT14 SNP as a potential predictor of response to combination chemotherapy using 5-FU, mitoxantrone and cisplatin in advanced HCC.
Kung-Hao Liang
,
Chen-Chun Lin
,
C. Yeh
Pharmacogenomics (London)
2011
Corpus ID: 30138007
AIM Despite the availability of targeted anticancer agents, combination chemotherapy remains an option for patients with far…
Expand
2010
2010
Development of Immunohistochemistry Assays to Assess GALNT14 and FUT3/6 in Clinical Trials of Dulanermin and Drozitumab
H. Stern
,
M. Padilla
,
K. Wagner
,
L. Amler
,
A. Ashkenazi
Clinical Cancer Research
2010
Corpus ID: 120941
Purpose: In vitro sensitivity to the proapoptotic receptor agonists dulanermin (rhApo2L/TRAIL) and drozitumab (DR5-agonist…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE